DCGI approves Phase 2/3 clinical trial of Covaxin in age group of 2-18

Bharat Biotech to conduct trials in 525 healthy volunteers

May 13, 2021 10:59 am | Updated 10:59 am IST - NEW DELHI:

A medic administers the first dose of Covaxin vaccine, in New Delhi. File

A medic administers the first dose of Covaxin vaccine, in New Delhi. File

The National Regulator of the country, the Drugs Controller General of India (DCGI), has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covaxin (COVID-19 vaccine) in the age group 2 to 18 years to its manufacturer Bharat Biotech Ltd. on May 12.

Also read: Can Covaxin booster dose prolong protection?

A release issued by the Health Ministry on Thursday said that Bharat Biotech International Ltd., Hyderabad, (BBIL), had proposed to carry out a Phase-II/III clinical trial of Covaxin in the age group of 2 to 18 years. The trial will be conducted in 525 healthy volunteers.

“In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28,” noted the release.

The Ministry added that as rapid regulatory response, the proposal was deliberated in Subject Expert Committee (SEC) (COVID-19) on May 11. The Committee after detailed deliberation recommended for grant of permission to conduct proposed Phase II/III clinical trial to certain conditions.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.